Jefferies Boosts PT on Celldex Therapeutics (CLDX) to $15

March 8, 2013 8:35 AM

Jefferies raised

its price target on Buy-rated Celldex Therapeutics (NASDAQ: CLDX) from $9 to $15.

The firm comments, "CLDX ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)